Mirum Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Mirum Pharmaceuticals, Inc.‘s stocks are currently a part of 59 hedge funds’ portfolios, which represents 21.3% of the total amount of its stocks outstanding. This makes up a total of 7.23M shares of Mirum Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -78.28% or -26.09M shares fewer. As for the holding position changes, 33.9% (20) of current hedge fund investors increased the number of shares held, 35.59% (21) of current holders sold a part of the shares held, and 8.47% (5) closed the holdings completely. 10 hedge funds are new holders of Mirum Pharmaceuticals, Inc. stock in Q1 2023, it is 16.95% of total holders.
Hedge funds holding Mirum Pharmaceuticals (Q3 2019 – Q1 2023)
| Q3 2019 | 39 |
|---|---|
| Q4 2019 | 39 |
| Q1 2020 | 43 |
| Q2 2020 | 57 |
| Q3 2020 | 50 |
| Q4 2020 | 72 |
| Q1 2021 | 61 |
| Q2 2021 | 67 |
| Q3 2021 | 72 |
| Q4 2021 | 84 |
| Q1 2022 | 98 |
| Q2 2022 | 106 |
| Q3 2022 | 110 |
| Q4 2022 | 101 |
| Q1 2023 | 59 |
Hedge funds changes in Mirum Pharmaceuticals positions (Q3 2019 – Q1 2023)
| Q3 2019 | 39 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2019 | 14 | 12 | 7 | 9 | -3 |
| Q1 2020 | 9 | 21 | 4 | 5 | 4 |
| Q2 2020 | 20 | 16 | 8 | 6 | 7 |
| Q3 2020 | 1 | 20 | 19 | 8 | 2 |
| Q4 2020 | 26 | 23 | 12 | 4 | 7 |
| Q1 2021 | 8 | 22 | 16 | 19 | -4 |
| Q2 2021 | 10 | 21 | 23 | 3 | 10 |
| Q3 2021 | 14 | 23 | 21 | 8 | 6 |
| Q4 2021 | 23 | 27 | 19 | 10 | 5 |
| Q1 2022 | 28 | 23 | 29 | 14 | 4 |
| Q2 2022 | 21 | 46 | 22 | 11 | 6 |
| Q3 2022 | 18 | 47 | 27 | 14 | 4 |
| Q4 2022 | 15 | 47 | 24 | 22 | -7 |
| Q1 2023 | 10 | 20 | 21 | 5 | 3 |
Hedge funds changes in Mirum Pharmaceuticals stock options (Q3 2019 – Q1 2023)
| Q3 2019 | 0 | 0 |
|---|---|---|
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 1,100,000 | 606,000 |
| Q4 2021 | 787,000 | 643,000 |
| Q1 2022 | 904,000 | 641,000 |
| Q2 2022 | 3,000 | 603,000 |
| Q3 2022 | 374,000 | 10,000 |
| Q4 2022 | 422,200 | 137,500 |
| Q1 2023 | 9,689,000 | 0 |